HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipoxin A4 ameliorates cerebral ischaemia/reperfusion injury through upregulation of nuclear factor erythroid 2-related factor 2.

AbstractOBJECTIVES:
Lipoxin A4 (LXA4) is a potent anti-inflammatory mediator that exerts a neuroprotective effect following cerebral ischaemia/reperfusion (I/R) injury. However, little is known about the underlying mechanisms. Upregulation of nuclear factor erythroid 2-related factor 2 (Nrf2) is generally considered to reduce cerebral I/R injury. Nuclear factor erythroid 2-related factor 2 can induce haeme oxygenase-1 (HO-1) and glutathione (GSH) expression to combat increased oxidative stress. The present study aimed to investigate the effects of Nrf2 signalling on LXA4-mediated neuroprotection.
METHODS:
Adult male Sprague Dawley rats were subjected to 2-hour middle cerebral artery occlusion followed by 24-hour reperfusion. Rats were randomly divided into four groups: Sham, I/R, LXA4, and LXA4+butoxycarbonyl-Phe-Leu-Phe-Leu-Phe (Boc2) (all n = 24). Brain infarction was detected by 2,3,5-triphenyltetrazolium chloride staining. After 24 hours of reperfusion, Nrf2, HO-1, and p62 expression levels were determined by western blot, and GSH synthesis was assessed.
RESULTS:
Lipoxin A4 effectively reduced infarct volumes and improved neurological scores. These effects were partially blocked by Boc2, a specific antagonist of the LXA4 receptor (ALXR). Lipoxin A4 induced Nrf2 expression and its nuclear translocation, as well as HO-1 expression and GSH synthesis; Boc2 did not block these effects. The excess p62 accumulation induced by LXA4 might be closely related to Nrf2 activation.
DISCUSSION:
Overall, our data suggest that Nrf2 upregulation is involved in the neuroprotective effects of LXA4 and may be ALXR independent.
AuthorsLe Wu, Zi Jian Liu, Sen Miao, Lin Bing Zou, Lei Cai, Ping Wu, Du Yun Ye, Qiang Wu, Hong Hua Li
JournalNeurological research (Neurol Res) Vol. 35 Issue 9 Pg. 968-75 (Nov 2013) ISSN: 1743-1328 [Electronic] England
PMID23880501 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Heat-Shock Proteins
  • Lipoxins
  • NF-E2-Related Factor 2
  • Neuroprotective Agents
  • Nfe2l2 protein, rat
  • Oligopeptides
  • Sequestosome-1 Protein
  • Sqstm1 protein, rat
  • lipoxin A4
  • butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine
  • Heme Oxygenase (Decyclizing)
  • Hmox1 protein, rat
  • Glutathione
Topics
  • Animals
  • Blotting, Western
  • Brain (metabolism, pathology)
  • Glutathione (metabolism)
  • Heat-Shock Proteins (metabolism)
  • Heme Oxygenase (Decyclizing) (metabolism)
  • Infarction, Middle Cerebral Artery (drug therapy, metabolism, pathology)
  • Lipoxins (therapeutic use)
  • Male
  • NF-E2-Related Factor 2 (metabolism)
  • Neuroprotective Agents (therapeutic use)
  • Oligopeptides (pharmacology)
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (drug therapy, metabolism, pathology)
  • Sequestosome-1 Protein
  • Severity of Illness Index
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: